Even more significant was the earlier announcement that the company was recalling their loaned shares.
"The penny stock company said just days before Shkreli's purchase that "it would wind down operations and liquidate assets, adding that any expectation of strategic alternatives were "highly unlikely." The company said it would discontinue two development programs, in Phase 1 and Phase 2 stage, adding it would not be able to file its Form 10-Q for the third quarter."
Shkreli has since been named the chief executive officer of KaloBios. A stock that at one point traded below $0.50 per share this year hit a high of $45.82 last week. On Thursday afternoon, Shkreli some other interesting news.
"I spoke with my counsel & advisers and decided to stop lending my $KBIO shares out until I better understand the advantages of doing so," Shkreli said. "I apologize for any inconvenience this may create in lending markets and I will probably resume lending at some point. Happy Thanksgiving!"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.